Masuyama and colleagues[28] also suggested that PXR-CYP3A4/7 signaling may serve as an oncogenic alternative pathway that contributes to carcinogenesis in endometrial cancer tissues with low ER-α status. The gene discussed is CYP3A4; the disease is endometrial cancer.